Latest stories on GERN
Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis
StockTitan56 · neutralproduct/pr
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire50 · neutralgeneral
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
Business Insider50 · neutralgeneral
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
PR Newswire34 · bearishgeneral
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia
GlobeNewswire58 · neutralproduct/pr
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia
StockTitan56 · neutralproduct/pr
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
PR Newswire34 · bearishgeneral
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Geron Eyes High End of 2026 RYTELO Revenue Guidance as Community Adoption Expands
Yahoo Top63 · neutralearnings
Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands
Yahoo Top67 · bullishproduct/pr
Kuehn Law Encourages Investors of Geron Corporation to Contact Law Firm
PR Newswire34 · bearishgeneral
Geron to Present at Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Geron to Present at Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Geron Corp.: Management's Plan Taking Shape As Competition Heats Up In Myelofibrosis
Seeking Alpha63 · neutralproduct/pr
GERON CORP (GERN) files 8-K
SEC 8-K50 · neutralgeneral
Geron (GERN) Q2 2026 Earnings Call Transcript
The Motley Fool59 · neutralearnings
Geron Corporation Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
Geron adds a record 16% as Rytelo drives Q2 revenue beat
Seeking Alpha73 · bullishearnings
Geron Delivers Strong Revenue Growth with RYTELO in Q2 2026 as Cash Position Remains Solid
August 5, 2026
MarketChameleon67 · bullishearnings
Geron Corporation (GERN) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings